These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9466136)

  • 1. Fat ingestion is associated with increased levels of apoC-III- and apoE-B-containing lipoprotein particles in humans.
    Dallongeville J; Baugé E; Lebel P; Fruchart JC
    Eur J Clin Invest; 1997 Dec; 27(12):1055-60. PubMed ID: 9466136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content.
    Khoo C; Campos H; Judge H; Sacks FM
    J Lipid Res; 1999 Feb; 40(2):202-12. PubMed ID: 9925648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.
    Campos H; Perlov D; Khoo C; Sacks FM
    J Lipid Res; 2001 Aug; 42(8):1239-49. PubMed ID: 11483625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three fatty meals in healthy normolipidaemic men: high post-prandial retinyl ester response to soybean oil.
    Mero N; Syvänne M; Rosseneu M; Labeur C; Hilden H; Taskinen MR
    Eur J Clin Invest; 1998 May; 28(5):407-15. PubMed ID: 9650015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia.
    Annuzzi G; Holmquist L; Carlson LA
    Scand J Clin Lab Invest; 1989 Feb; 49(1):73-81. PubMed ID: 2727620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde.
    Luc G; Fievet C; Arveiler D; Evans AE; Bard JM; Cambien F; Fruchart JC; Ducimetiere P
    J Lipid Res; 1996 Mar; 37(3):508-17. PubMed ID: 8728314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV
    Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
    Tam SP; Dory L; Rubinstein D
    J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
    Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
    Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
    Batal R; Tremblay M; Barrett PH; Jacques H; Fredenrich A; Mamer O; Davignon J; Cohn JS
    J Lipid Res; 2000 May; 41(5):706-18. PubMed ID: 10787431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan.
    Olin-Lewis K; Krauss RM; La Belle M; Blanche PJ; Barrett PH; Wight TN; Chait A
    J Lipid Res; 2002 Nov; 43(11):1969-77. PubMed ID: 12401896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients.
    Marcoux C; Tremblay M; Nakajima K; Davignon J; Cohn JS
    J Lipid Res; 1999 Apr; 40(4):636-47. PubMed ID: 10191287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.
    Fredenrich A; Giroux LM; Tremblay M; Krimbou L; Davignon J; Cohn JS
    J Lipid Res; 1997 Jul; 38(7):1421-32. PubMed ID: 9254067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.
    Zheng C; Khoo C; Furtado J; Sacks FM
    Circulation; 2010 Apr; 121(15):1722-34. PubMed ID: 20368524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELISA quantitation of apolipoproteins in plasma lipoprotein fractions: ApoE in ApoB-containing lipoproteins (Lp B:E) and ApoB in ApoE-containing lipoproteins (Lp E:B).
    Yang CY; Xie YH; Yang M; Quion JA; Gotto AM
    J Protein Chem; 1995 Oct; 14(7):503-9. PubMed ID: 8561846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high carbohydrate-fat free diet alters the proportion of heparin-bound VLDL in plasma and the expression of VLDL-apoB-100 epitopes.
    Keidar S; Goldberg AC; Cook K; Bateman J; Schonfeld G
    Metabolism; 1990 Mar; 39(3):281-8. PubMed ID: 2308518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia.
    Sacks FM
    Curr Opin Lipidol; 2015 Feb; 26(1):56-63. PubMed ID: 25551803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
    Breyer ED; Le NA; Li X; Martinson D; Brown WV
    J Lipid Res; 1999 Oct; 40(10):1875-82. PubMed ID: 10508207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.